A
Akashi Therapeutics
0 followers
Akashi Therapeutics is a clinical stage biotechnology company developing a portfolio of products for Duchenne muscular dystrophy and other rare diseases.
Org chart
Board & advisors
Tracy Seckler
Director
Anthony Amato
Scientific Advisor
Jeffrey Chamberlain
Scientific Advisor
Merit Cudowitz
Scientific Advisor
Francesco Muntoni
Scientific Advisor
Robert Pacifici
Scientific Advisor
Dominic Wells
Scientific Advisor
Cristina Csimma
Business Advisor
John Dyett
Business Advisor
Bahaa W. Fam
Business Advisor
Benjamin Seckler
Co-founder